|
Category: nutrient supplements
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 264.00 to 265.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.002890 mmHg @ 25.00 °C. (est) |
| Flash Point: | 236.00 °F. TCC ( 113.50 °C. ) (est)
|
| logP (o/w): | -0.669 (est) |
| Soluble in: |
| | water |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-rat LD50 4850 mg/kg BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: ATAXIA
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
intravenous-rat LD50 216 mg/kg New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
oral-mouse LD50 5566 mg/kg BEHAVIORAL: TREMOR
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: ATAXIA New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
oral-dog LDLo 5000 mg/kg GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH
GASTROINTESTINAL: ULCERATION OR BLEEDING FROM DUODENUM New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
|
| Dermal Toxicity: |
subcutaneous-rat LD50 1950 mg/kg New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
subcutaneous-mouse LD50 1020 mg/kg New Cardiovascular Drugs. Vol. 4, Pg. 243, 1986.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | nutrient supplements |
| Recommendation for magnesium laevo-aspartate hydrochloride trihydrate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for magnesium laevo-aspartate hydrochloride trihydrate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| European Food Safety Authority (EFSA) reference(s): |
Magnesium aspartate, potassium aspartate, magnesium potassium aspartate, calcium aspartate, zinc aspartate, and copper aspartate as sources for magnesium, potassium, calcium, zinc, and copper added for nutritional purposes to food supplements - Scientific Panel on Food Additives and Nutrient Sources added to food (ANS) View page or View pdf |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 161595 |
| National Institute of Allergy and Infectious Diseases: | Data |
| | magnesium; 2-aminobutanedioate; hydron; chloride |
| Chemidplus: | 0028184716 |
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| (L- | aspartato(2-)-N,O(sup 1),O(sup 4))chloromagnesate(1-) hydrogen (T-4) trihydrate | | | magnesate(1-), (L-aspartato(2-)-N,O(sup 1),O(sup 4))chloro-, hydrogen, (T-4), trihydrate | | | magnesium L-aspartate hydrochloride (1:1:1) | | | magnesium L-aspartate hydrochloride trihydrate | | | magnesium laevo-aspartate hydrochloride (1:1:1) | | | magnesium; 2-aminobutanedioate; hydron; chloride |
Articles:
|